Search
News
Important Only
Zenas Biopharma Announces First Subject Dosed In Phase 1 Clinical Trial Of Zb021, A Novel, Potentially Best-In-Class Oral Il-17Aa/Af Inhibitor
Zenas Biopharma Inc ZBIO.O:ZENAS BIOPHARMA ANNOUNCES FIRST SUBJECT DOSED IN PHASE 1 CLINICAL TRIAL OF ZB021, A NOVEL, POTENTIALLY BEST-IN-CLASS ORAL IL-17AA/AF INHIBITORReuters
5 hours ago
Groupon Shareholder Nick Nemeth Urges Board To Revamp Platform, Rebrand For The Thrifting Generation, And Accelerate Buybacks
Groupon Inc GRPN.O:GROUPON SHAREHOLDER NICK NEMETH URGES BOARD TO REVAMP PLATFORM, REBRAND FOR THE THRIFTING GENERATION, AND ACCELERATE BUYBACKSNICK NEMETH: DO NOT CALL FOR MANAGEMENT CHANGE, BOARD CHANGE, OR STRATEGIC ALTERNATIVES AT GROUPONReuters
5 hours ago
Britain to strengthen ties with the EU in new legislation
By Alistair Smout LONDON, May 13 (Reuters) - Britain will introduce legislation to strengthen its ties with the European Union, as Prime Minister Keir Starmer prioritises mending economic relations with the bloc as he tries to stay in power following growing calls for him to quit.Outlining the go...Reuters
5 hours ago
Kremlin says big deals can be done if US stops linking trade ties to Ukraine
MOSCOW, May 13 (Reuters) - Russia is interested in pursuing a range of joint economic projects with the United States if Washington stops linking trade ties with a peace deal on Ukraine, the Kremlin said on Wednesday.Russia sees an array of potential mutually beneficial projects with the U.S., Kreml...Reuters
5 hours ago
European Commission Approves Pfizer’S Hympavzi For The Treatment Of Adults And Adolescents With Hemophilia A Or B With Inhibitors
May 13 (Reuters) - Pfizer Inc PFE.N:EUROPEAN COMMISSION APPROVES PFIZER’S HYMPAVZI FOR THE TREATMENT OF ADULTS AND ADOLESCENTS WITH HEMOPHILIA A OR B WITH INHIBITORSPFIZER : EUROPEAN COMMISSION APPROVES HYMPAVZI EXPANSION FOR HEMOPHILIA A/B PATIENTS AGES 12+ WITH INHIBITORSPFIZER - HYMPAVZI MARKETIN...Reuters
5 hours ago
Aevex Secures $18.5 mln Contract For Delivery Of UAS And Engineering Services To U.S. Air Force
May 13 (Reuters) - AEVEX Corp AVEX.N:AEVEX SECURES $18.5M CONTRACT FOR DELIVERY OF UAS AND ENGINEERING SERVICES TO U.S. AIR FORCEAEVEX CORP - CONTRACT INCLUDES ENGINEERING AND FIELD SERVICES SUPPORTReuters
5 hours ago
Eos Energy Q1 revenue jumps 445% but misses estimates
OverviewUS zinc-based battery maker's Q1 revenue surged 445% yr/yr but missed analyst expectationsCompany achieved record production and shipments, driven by automation and higher deliveriesEntered 2 GWh capacity reservation agreement with Frontier Power USA to accelerate deploymentsOutlookEos r...Reuters
5 hours ago
German yields close to multi-year highs; UK gilts also in frame
German yields little changed as Iran negotiations stallUBS says market pricing of ECB rate outlook too hawkishUK political developments also in focusBy Stefano Rebaudo May 13 (Reuters) - German government bond yields broke a four-day rise on Wednesday but remained near multi-year highs, with inve...Reuters
5 hours ago
Immunic Q1 net loss widens on higher R&D spends
OverviewUS biotechnology firm's Q1 net loss widened to $32.6 mln, or $1.08 per shareCompany raised $200 mln in private placement, boosting cash to $186.6 mlnOutlookImmunic expects to fund operations into late 2027 with current cash positionResult DriversR&D SPENDING - Higher research and dev...Reuters
5 hours ago
DarioHealth Q1 revenue rises sequentially, operating loss narrows on cost reductions
OverviewDigital health platform's Q1 revenue rose sequentially but fell yr/yr due to one-time prior revenueOperating expenses fell 21% yr/yr and operating loss narrowed 22% yr/yrCompany added 10 new accounts and expanded channel partnerships, now reaching 116 mln covered livesOutlookDarioHealth ...Reuters
5 hours ago
Israel's Valens Semiconductor Q1 revenue beats on automotive segment growth
OverviewIsrael connectivity chipmaker's Q1 revenue beat analyst expectationsQ1 pretax profit missed analyst expectationsOutlookValens expects Q2 2026 revenue of $17.2 mln to $17.6 mlnCompany sees Q2 2026 gross margin between 60% and 62%Valens forecasts Q2 2026 adjusted EBITDA loss of $4.9 mln to...Reuters
5 hours ago
Veru Q2 net loss narrows as expenses decline
OverviewUS biopharma firm's fiscal Q2 net loss narrowed year-over-yearResearch and development and administrative expenses both declined from prior yearOutlookCompany plans to prioritize internal cash for enobosarm development; advancement of sabizabulin depends on new fundingResult DriversEXPEN...Reuters
5 hours ago
UK's Compass Pathways Q1 operating income beats estimates as expenses fall
OverviewUK mental health biotech's Q1 operating income beat analyst expectations as expenses declinedCompany posted net income of $91.2 mln, driven by non-cash warrant revaluation gainCash position rose to $466 mln, expected to fund operations into 2028OutlookCOMPASS Pathways expects final NDA s...Reuters
5 hours ago
Dynatrace Q4 revenue rises 19%, adjusted EPS beats estimates
OverviewAI observability platform's Q4 revenue rose 19%, beating analyst expectationsAdjusted EPS for Q4 beat analyst expectationsCompany boosted Q4 share repurchases by 40% to $224 mlnOutlookDynatrace sees FY27 ARR between $2.382 bln and $2.402 bln, up 16%-17% as reportedCompany expects FY27 to...Reuters
5 hours ago
Westwater Resources Q1 net loss widens
OverviewUS battery-grade graphite firm's Q1 net loss widened yr/yrCompany attributes higher loss to increased permitting, stock compensation, and product development costsOutlookCompany continues to pursue non-dilutive and lower-cost capital, including government fundingResult DriversHIGHER PERM...Reuters
5 hours ago
Aprea Therapeutics Q1 net loss narrows as R&D expenses fall
OverviewUS precision oncology firm's Q1 net loss narrowed yr/yr as R&D expenses declinedCash and cash equivalents rose to $46.5 mln after $30 mln private placementCompany observed two partial responses in ongoing Phase 1 APR-1051 trialOutlookCompany anticipates cash runway into Q1 2028Result...Reuters
5 hours ago
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying
April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide
Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End
SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today
Market Movers
Palantir Technologies Inc Stock (PLTR) Moved Down by 4.31% on May 13: What Investors Need To Know
41 minutes ago
GOOGL
--
Arm Holdings PLC Stock (ARM) Moved Up by 4.13% on May 13: What Investors Need To Know
41 minutes ago
ARM
--
Toyota Motor Corp Stock (TM) Moved Up by 3.13% on May 13: Facts Behind the Movement
41 minutes ago
F
--
Tradingkey
